Pharmaceutical industry news

Mirum Pharmaceuticals Hires LMH Strategic Solutions

Guy’s and St Thomas’ plans transition to a new Trust Chair

Meningococcal disease: guidance, data and analysis

The characteristics, diagnosis, management, surveillance and epidemiology of meningococcal disease.

Adult social care client level data, England: quarterly update to June 2027

Official statistics in development on insights from client level data from local authorities, includ...

ICON taps Anthropic and Microsoft as it puts clinical-trial agents into production

Adult social care client level data, England: quarterly update to September 2026

Official statistics in development on insights from client level data from local authorities, includ...

Opus Genetics Announces Positive Low Dose Cohort 1 Data from Phase 1/2 Clinical Trial of OPGx-BEST1 and Successful FDA Type C Meeting with Potential Phase 3 Dosing in 2027

Kane Biotech to Host Commercial Update Webcast on September 16

The Cancer Aftermath of the 9/11 Attacks on First Responders

111-patient eye pain trial planned by OKYO Pharma (NASDAQ: OKYO)

Algorithmic tool may improve screening of patients for an Alzheimer's clinical trial

FDA is still reviewing Rezolute’s experimental drug. No timeline is set.

Beeline flies into ph. 3 as oral lupus drug soars past placebo

Exclusive: Cancer biotech TwoStep gets $62.5M to take twist on ADCs into clinic

Matica Biotechnology and Bondwell Technologies Collaborate to Advance Texas Biotech Innovation

Schrödinger births new immunology and inflammation biotech, Tectora Therapeutics

Solstice rises with $225M series A to advance next-gen CTLA-4 immunotherapy into phase 2

The Manufacturing Questions Facing Chinese Biotech

Moonwalk banks $70m to progress siRNA therapy for obesity

“Unparalleled opportunity”: Sandoz embarks on ambitious biosimilar growth strategy

MannKind and Rose Pharma Inc Enter Licensing and Collaboration Agreement to Develop an Inhaled Rapid-Acting, Short-Duration GLP-1 for Weight Management

Sindrome da trasfusione feto fetale: il volo in urgenza da Cosenza e l’intervento in utero al Policlinico di Milano per salvare due gemellini

A rapid-acting, short-duration inhaled treatment is being developed for weight management

Compass Pathways’ New 52-Week Topline Open-Label Data from Phase 3 COMP005 Trial Demonstrates Additional Benefit from Another COMP360 Dose in Part C Extending Durability Out to 1 Year

What Makes Pharmaceutical Speaker Programs Illegal?

A global eye cancer trial has dosed its first patient

Biden-era abortion by mail rules face key test at appeals court hearing

The University Library will be closed on 17 September

NAFDAC and NHREC Announce New Dates for Mandatory Stakeholders Training on Clinical Trial Regulations in Nigeria

Gram-negative, MRSA, MSSA bacteraemia and C. difficile infections among independent sector providers: experimental statistics, April 2025 to March 2026

Surveillance of healthcare-associated infections (HCAI); MRSA, MSSA and Gram-negative bacteremia (Es...

Neuromuscular drug from Novartis fails in key study, adding to pressure on company

Une revue de référence publiée dans le New England Journal of Medicine sur les myéloproliférations néoplasiques

PACK EXPO: seamless pharma processes for North America

„Wissen und Praxis – Hand in Hand“: Expertinnen und Experten aus der Zahnerhaltungskunde tagen am UKHD

Ebola disease: information sheet for category 4 returnees from an Ebola-affected area

Advice for workers returning from an Ebola-affected area who have had high risk contact with Ebola.

Ebola disease: information sheet for category 3 returnees from an Ebola-affected area

Advice for workers returning from an Ebola-affected area who have had contact with someone with Ebol...

Ebola disease: information sheet for category 2 returnees from an Ebola-affected area

Advice for workers returning from an Ebola-affected area who have been close to someone with Ebola w...

Ebola disease: information sheet for category 1 returnees from an Ebola-affected area

Advice for workers returning from an Ebola-affected area.

Ebola and Marburg: contact matrix for Returning Workers Scheme and non-UK exposures

Public health recommendations for asymptomatic contacts of Marburg virus disease (MARD) or Ebola dis...

Ebola virus disease: clinical management and guidance

Guidance, resources and information for professionals about Ebola virus disease, a severe viral haem...

Ebola returning workers scheme: public health advice

Advice on the risk classification of workers returning from an Ebola-affected area and public health...

AlphaGenome Variant Impact scores integrated into Ensembl VEP

Barclays upgrades Sagimet stock rating on acne drug potential

Oral Infigratinib Shows Meaningful Benefits Beyond Growth Within 52 Weeks in Children with Achondroplasia in the Phase 3 PROPEL 3 Trial

A sleep-apnea measure rose 10.4% with an experimental drug, versus 49.2% with placebo

Mosliciguat Advances to Phase 3 PHrontier Trial After PHocus Study Shows 20% PVR Reduction

Proteomic Aging Clocks Just Changed What a Phase 2a Trial Has to Prove

Medicine shortages grow in Iran as US tightens sanctions, blockade

The Covid-19 Pandemic Memorial Site opens to the public

5 questions that could determine Alzheimer’s next chapter

Deconstructing LSD for therapeutic discoveries

Reading app boosts kids’ literacy

Maharashtra FDA Cracks Down on Food Safety Violators

Maharashtra FDA suspends food licenses of railway catering supplier, 20 eateries over alleged violations of safety norms

Steady stream of crossover rounds stock biotech’s IPO pipeline

Electrogram‐Guided Driver Ablation Versus Posterior Wall Isolation in Persistent AF: A Propensity‐Matched Study

[IBENTO][IBENTO]Report on the PMDA Hokuriku Branch 10th Anniversary Symposium

Rezubio doses first patients in phase I trial of inhaled respiratory drug RZ-520

Taiwan's Obigen Pharma to Unblind Phase 3 Botox Trial Early in November; Year-End Cash Raise to Top NT$400 Million

Rezubio doses first patients in phase I trial of inhaled respiratory drug RZ-520